{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T22:07:58Z","timestamp":1783030078682,"version":"3.54.6"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"DOI":"10.7759\/cureus.86195","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:14:44Z","timestamp":1750155284000},"source":"Crossref","is-referenced-by-count":1,"title":["Giant Cell Arteritis With Atypical Features: Acute Vision Loss and Marked Eosinophilia Mimicking Systemic Vasculitis"],"prefix":"10.7759","author":[{"given":"David","family":"Phrathep","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina A","family":"Billings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamaad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mohseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.322128","article-title":"Immunology of giant cell arteritis","volume":"132","author":"Weyand CM","year":"2023","unstructured":"Weyand CM, Goronzy JJ. Immunology of giant cell arteritis. Circ Res. 2023, 132:238-50. 10.1161\/CIRCRESAHA.122.322128","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/cells13030267","article-title":"Giant cell arteritis: advances in understanding pathogenesis and implications for clinical practice","volume":"13","author":"Paroli M","year":"2024","unstructured":"Paroli M, Caccavale R, Accapezzato D. Giant cell arteritis: advances in understanding pathogenesis and implications for clinical practice. Cells. 2024, 13:10.3390\/cells13030267","journal-title":"Cells"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab507","article-title":"All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study","volume":"61","author":"Therkildsen P","year":"2022","unstructured":"Therkildsen P, Nielsen BD, de Thurah A, Hansen IT, N\u00f8rgaard M, Hauge EM. All-cause and cause-specific mortality in patients with giant cell arteritis: a nationwide, population-based cohort study. Rheumatology (Oxford). 2022, 61:1195-203. 10.1093\/rheumatology\/keab507","journal-title":"Rheumatology (Oxford)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder GG","year":"1990","unstructured":"Hunder GG, Bloch DA, Michel BA, et al.. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990, 33:1122-8. 10.1002\/art.1780330810","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061588","article-title":"Advances in the treatment of giant cell arteritis","volume":"11","author":"Casta\u00f1eda S","year":"2022","unstructured":"Casta\u00f1eda S, Prieto-Pe\u00f1a D, Vicente-Rabaneda EF, et al.. Advances in the treatment of giant cell arteritis. J Clin Med. 2022, 11:10.3390\/jcm11061588","journal-title":"J Clin Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24632","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz M","year":"2021","unstructured":"Maz M, Chung SA, Abril A, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Care Res (Hoboken). 2021, 73:1071-87. 10.1002\/acr.24632","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/art.41774","article-title":"2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis","volume":"73","author":"Maz M","year":"2021","unstructured":"Maz M, Chung SA, Abril A, et al.. 2021 American College of Rheumatology\/Vasculitis Foundation guideline for the management of giant cell arteritis and Takayasu arteritis. Arthritis Rheumatol. 2021, 73:1349-65. 10.1002\/art.41774","journal-title":"Arthritis Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05160-x","article-title":"Vision loss in giant cell arteritis: case-based review","volume":"42","author":"Kokloni IN","year":"2022","unstructured":"Kokloni IN, Aligianni SI, Makri O, Daoussis D. Vision loss in giant cell arteritis: case-based review. Rheumatol Int. 2022, 42:1855-62. 10.1007\/s00296-022-05160-x","journal-title":"Rheumatol Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(01)00770-7","article-title":"Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients","volume":"111","author":"Liozon E","year":"2001","unstructured":"Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, Vidal E. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001, 111:211-7. 10.1016\/s0002-9343(01)00770-7","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/24725625.2021.1893944","article-title":"Temporal arteritis as an initial manifestation of eosinophilic granulomatosis with polyangiitis: a case report and a literature review","volume":"5","author":"Nishimura T","year":"2021","unstructured":"Nishimura T, Hosai M, Yamasaki R, Oiwa H. Temporal arteritis as an initial manifestation of eosinophilic granulomatosis with polyangiitis: a case report and a literature review. Mod Rheumatol Case Rep. 2021, 5:337-41. 10.1080\/24725625.2021.1893944","journal-title":"Mod Rheumatol Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013199.pub2","article-title":"Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis","volume":"2","author":"Pouncey AL","year":"2024","unstructured":"Pouncey AL, Yeldham G, Magan T, Lucenteforte E, Jaffer U, Virgili G. Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis. Cochrane Database Syst Rev. 2024, 2:CD013199. 10.1002\/14651858.CD013199.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkab059","article-title":"Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis","volume":"5","author":"Sebastian A","year":"2021","unstructured":"Sebastian A, Coath F, Innes S, Jackson J, van der Geest KS, Dasgupta B. Role of the halo sign in the assessment of giant cell arteritis: a systematic review and meta-analysis. Rheumatol Adv Pract. 2021, 5:rkab059. 10.1093\/rap\/rkab059","journal-title":"Rheumatol Adv Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.885463","article-title":"Giant cell arteritis presenting with ocular symptoms: clinical characteristics and multimodal imaging in a Chinese case series","volume":"9","author":"Chen Q","year":"2022","unstructured":"Chen Q, Chen W, Feng C, et al.. Giant cell arteritis presenting with ocular symptoms: clinical characteristics and multimodal imaging in a Chinese case series. Front Med (Lausanne). 2022, 9:885463. 10.3389\/fmed.2022.885463","journal-title":"Front Med (Lausanne)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11071997","article-title":"Ocular complications of giant cell arteritis: an acute therapeutic emergency","volume":"11","author":"H\u00e9ron E","year":"2022","unstructured":"H\u00e9ron E, Sedira N, Dahia O, Jamart C. Ocular complications of giant cell arteritis: an acute therapeutic emergency. J Clin Med. 2022, 11:10.3390\/jcm11071997","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/379316-giant-cell-arteritis-with-atypical-features-acute-vision-loss-and-marked-eosinophilia-mimicking-systemic-vasculitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T10:14:48Z","timestamp":1750155288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/379316-giant-cell-arteritis-with-atypical-features-acute-vision-loss-and-marked-eosinophilia-mimicking-systemic-vasculitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.86195","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,17]]}}}